"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours. (6th November 2014) - Champion, Brian R; Kodialbail, Prithvi; Illingworth, Sam; Rasiah, Nalini; Cochrane, Dan; Beadle, John; Fisher, Kerry; Brown, Alice CN